aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis (Journal of Hepatology, 2020)

(untitled) - Fan, R; Papatheodoridis, G; Sun, J; Innes, H; Toyoda, H; Xie, Q; Mo, S; Sypsa, V; Guha, IN; Kumada, T; Niu, J; Dalekos, G; et al.